A call to action: Community pharmacists to address COVID-19-related behavioral health concerns.
J Am Pharm Assoc (2003)
; 61(3): e75-e77, 2021.
Article
in English
| MEDLINE | ID: covidwho-1272512
ABSTRACT
Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Depressive Disorder, Major
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Am Pharm Assoc (2003)
Journal subject:
Pharmacy
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS